0000908662-15-000288.txt : 20150811
0000908662-15-000288.hdr.sgml : 20150811
20150811162902
ACCESSION NUMBER: 0000908662-15-000288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150807
FILED AS OF DATE: 20150811
DATE AS OF CHANGE: 20150811
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYAX CORP
CENTRAL INDEX KEY: 0000907562
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043053198
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
BUSINESS PHONE: 617-250-5769
MAIL ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTAGE INC
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KEMPNER THOMAS L
CENTRAL INDEX KEY: 0001091925
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24537
FILM NUMBER: 151044197
MAIL ADDRESS:
STREET 1: C/O LOEB PARTNERS CORPORATION
STREET 2: 125 BROAD STREET, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-08-07
0000907562
DYAX CORP
DYAX
0001091925
KEMPNER THOMAS L
C/O DYAX CORP.
55 NETWORK DRIVE
BURLINGTON
MA
01803-2756
1
0
0
0
Common Stock
2015-08-07
4
S
0
18600
23.8028
D
0
I
By Loeb Investors Co. IX
Common Stock
2015-08-07
4
S
0
37200
23.8028
D
577120
I
By Loeb Holding Corporation
Common Stock
2015-08-07
4
S
0
37200
23.8028
D
1034651
I
By Trust
Common Stock
2015-08-10
4
S
0
25000
23.8426
D
1009651
I
By Trust
Common Stock
2015-08-11
4
S
0
2800
23.8839
D
1006851
I
By Trust
Common Stock
5021
I
By Spouse
Common Stock
55041
D
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.57 to $23.895, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
The reporting person is the Managing Partner of Loeb Investors Co. IX. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
The reporting person is the Chairman, Chief Executive Officer, and also beneficial owner of a majority of the voting stock of Loeb Holding Corporation. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Shares held in trust, of which the reporting person is the trustee, for the benefit of the reporting person's brother's children, the reporting person's children, the reporting person's sister-in-law, and the reporting person.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.80 to $23.925, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 5.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.80 to $23.96, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 6.
/s/ Stacie S. Aarestad, as attorney-in-fact
2015-08-11